These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 11105457)
1. Clinical use of selective estrogen receptor modulators. Krueger PM J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S6-8. PubMed ID: 11105457 [TBL] [Abstract][Full Text] [Related]
2. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma. Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500 [TBL] [Abstract][Full Text] [Related]
3. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Lee WL; Chao HT; Cheng MH; Wang PH Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794 [TBL] [Abstract][Full Text] [Related]
4. [Which is the better choice, estrogen or SERMs in postmenopausal women?]. Shintani M Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140 [TBL] [Abstract][Full Text] [Related]
5. [Selective estrogen receptor modulators (SERMs) in the practice]. Nagykálnai T Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896 [TBL] [Abstract][Full Text] [Related]
6. Treatment of estrogen deficiency symptoms in women surviving breast cancer. Climacteric; 1998 Jun; 1(2):148-58. PubMed ID: 11907918 [No Abstract] [Full Text] [Related]
7. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
8. Raloxifene for the treatment and prevention of breast cancer? Pappas SG; Jordan VC Expert Rev Anticancer Ther; 2001 Oct; 1(3):334-40. PubMed ID: 12113100 [TBL] [Abstract][Full Text] [Related]
9. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies]. Maeda T; Ke HZ; Simmons H; Thompson D Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137 [TBL] [Abstract][Full Text] [Related]
13. [Menopause: are selective estrogen modulators (SERMs) an alternative treatment to hormonal replacement?]. Zárate A Gac Med Mex; 2001; 137(2):177-8. PubMed ID: 11381809 [No Abstract] [Full Text] [Related]
14. Pharmacology and clinical applications of selective estrogen receptor modulators. Nath A; Sitruk-Ware R Climacteric; 2009 Jun; 12(3):188-205. PubMed ID: 19387883 [TBL] [Abstract][Full Text] [Related]
15. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis]. Urano T Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770 [TBL] [Abstract][Full Text] [Related]
17. [Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology]. Terán Dávila J; Teppa Garrán AD Ginecol Obstet Mex; 2005 Aug; 73(8):424-35. PubMed ID: 16304968 [TBL] [Abstract][Full Text] [Related]
18. [SERMs for treatment of osteoporosis: state-of-the-art and perspectives]. Legrand E; Hoppé E; Chappard D; Audran M Gynecol Obstet Fertil; 2006 May; 34(5):423-8. PubMed ID: 16697240 [TBL] [Abstract][Full Text] [Related]
19. Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature. Saji S; Kuroi K Breast Cancer; 2008; 15(4):262-9. PubMed ID: 18654829 [TBL] [Abstract][Full Text] [Related]
20. [Role of estrogen and selective estrogen receptor modulators in anti-aging]. Ohta H Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]